The field of neurotherapeutics is expanding and ASENT is a unique space where academicians, industry leaders, government, advocacy can truly work together to impact the drug discovery and development process in neurotherapeutics. This includes payers, prescribers, startups and big pharma, researchers and clinicians, innovators and engineers, drug developers and device developers are all welcome and encouraged to join ASENT and become part of the conversation.
ASENT's scientific journal, Neurotherapeutics has a consistently high ranking impact factor and is led by our outstanding Editor in Chief, M. Maral Mouradian, MD, Rutgers University. All members receive complimentary access to these journals, as well as discounted APC rates for submitting research.
ASENT's highly recognized faculty cover the principles of clinical trials from pre-clinical programs to Phase III design and implementation, including necessary regulatory conversations and IND enabling studies, IRB oversight and adverse event tracking and reporting. The course considers clinical trials in the neurotherapeutic space for both drugs and devices. The course also addresses the unique challenges inherent in developing treatments for nervous system disorders.
The ASENT Career Center makes it simple to find and post open positions in the field of Neurotherapeutics, whether you are in industry, academia, government or advocacy. With postings that run the gamut from chief scientific officer to research scientist to department chair, the ASENT Career Center can help you or your team advance in the field.
Members receive a regular newsletter that includes highlights from the journal, the latest ASENT news and opportunities.
If you prefer you can select automatic renewal so you will never be interrupted when submitting an abstract or registering for the annual meeting.
Members are encouraged to participate on ASENT's Board and Program Committee. These committees are active and engaged and determine the direction of the organization.